Dermatological condition Primarily new onset or exacerbations Number of case reports Tendency to remit with lithium withdrawal Psoriasis (plaque or guttate) Exacerbations and new onset cases 44 Variable Maculopapular rashes…
© Springer International Publishing Switzerland 2017Gin S. Malhi, Marc Masson and Frank Bellivier (eds.)The Science and Practice of Lithium Therapy10.1007/978-3-319-45923-3_14 14. Lithium Discontinuation and Reintroduction Nicolas Schaad1, 2 and Jean-Michel Aubry3 (1) Pharmacie Interhospitalière de la Côte, Chemin…
© Springer International Publishing Switzerland 2017Gin S. Malhi, Marc Masson and Frank Bellivier (eds.)The Science and Practice of Lithium Therapy10.1007/978-3-319-45923-3_13 13. Lithium and Suicide Prevention Helen Jones1 , John Geddes1 and Andrea Cipriani2 (1) Psychiatry Department, University of Oxford, Oxford,…
Fig. 12.1 Flow diagram of factors influencing the likelihood of adherence The second component of the model suggests that, if symptoms occur, individuals will make some attempt to cope with…
© Springer International Publishing Switzerland 2017Gin S. Malhi, Marc Masson and Frank Bellivier (eds.)The Science and Practice of Lithium Therapy10.1007/978-3-319-45923-3_4 4. The Effect of Lithium on Gene Expression Modulation Alessio Squassina1, 2 , Claudia Pisanu1 and Martin Alda2 (1) Department…
© Springer International Publishing Switzerland 2017Gin S. Malhi, Marc Masson and Frank Bellivier (eds.)The Science and Practice of Lithium Therapy10.1007/978-3-319-45923-3_8 8. Lithium Response Variability (Pharmacogenomics Studies) Alexandre Dayer1 , Nader Perroud2 and Jean-Michel Aubry3 (1) Mood Disorders Unit, Division of…
Fig. 10.1 Timeline of key figures in relation to lithium (From Malhi and Gershon 2009) 10.5 Summary The 1950s was a prodigious decade for modern psychopharmacology. The principal efficient molecules…
© Springer International Publishing Switzerland 2017Gin S. Malhi, Marc Masson and Frank Bellivier (eds.)The Science and Practice of Lithium Therapy10.1007/978-3-319-45923-3_5 5. Neuroimaging and Lithium Josselin Houenou1, 2, 3, 4 , Chloé Benizri2, 3 and Barbara Jakubowicz2, 3, 4 (1) AP-HP,…
Study population No of subjects Type of XR Li Reference Observed pharmacokinetics parameters Normal control subjects 6 Lithium carbonate LP 400 mg (after 12 h) Hunter (1988) C max =…
Organ system Frequent symptoms Heart Chest pains, paroxysmal tachycardias Blood pressure Hypertension and hypotension regulation disorders, syncope Upper gastrointestinal tract Nausea, feeling of repletion, meteorism Lower gastrointestinal tract Pain, diarrhoea,…
